InsiderFlow

KANTOFF AARON

CNTA

KANTOFF AARON serves as Director at Centessa Pharmaceuticals plc (CNTA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$119.8K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$119.8K

Companies Traded

1

CNTA

Active Period

Nov 2021

1 total trades

Most Recent

Buy CNTA

Nov 18, 2021 · $119.8K

KANTOFF AARON's Insider Trading at Centessa Pharmaceuticals plc (CNTA)

Buys

1 · $119.8K

Sells

0 · $0.00

Total Shares Bought

10,000

Total Shares Sold

0

CNTA Price Chart
Loading chart...
DateTypeValue
Nov 18, 2021 Buy$119.8K

Related Insiders

Mario Alberto Accardi

President, Orexin Program

CNTASell · Feb 1, 2026

Karen M. Anderson

Chief People Officer

CNTASell · Feb 1, 2026

Tia L Bush

Chief Technology & Quality Ofc

CNTASell · Feb 1, 2026

Gregory M Weinhoff

Chief Business Officer

CNTASell · Feb 1, 2026

HUSSAIN IQBAL J

General Counsel

CNTASell · Jan 30, 2026

Explore More Insider Trading Data

CNTA Insider Trading Activity

View all insider trades at Centessa Pharmaceuticals plc

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity